Souza, Fabio E. S.,Bhattacharyya, Annyt,Khalili, Bahareh,Rey, Allan W.,Gorin, Boris
申请号：
AU2018203509
公开号：
AU2018203509A1
申请日:
2018.05.17
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2018203509A120191205.pdf#####ABSTRACT The present invention provides novel crystalline forms of Ibrutinib. Specific crystalline forms provided by the present invention include Ibrutinib Form APO-I, an anhydrous form； APO-I, a methyl benzoate solvate of 5 lbrutinib； and APO-IV, a methyl salicylate solvate of Ibrutinib. (Figure 3)3/8 FIG. 3 L C: 0 (n 0 r-c 0 0 0 L0
